Figure 3 Template for standard pelvic lymphadenectomy

Slides:

Advertisements

Similar presentations

Avascular Spaces of the Pelvis

Advertisements

Pelvic Nodal Consensus CTV Contours: High Risk/ Locally Advanced Adenocarcinoma of the Prostate Colleen A F Lawton MD Medical College of Wisconsin.

Pre-TME era. Mesorectal subsite/LN ALWAYS included in CTV Mesorectal subsite / LN region.

Urinary Bladder Anatomical sites of the urinary bladder. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer,

 T1 tumors at high risk of progression (high grade, multifocality, CIS, and tumor size, )  In all T1 patients failing intravesical therapy  muscle-invasive.

Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.

Nat. Rev. Urol. doi: /nrurol

Figure 3 Life expectancy at birth in all countries included

Figure 4 Types of urinary diversion

Figure 1 Male infertility and assisted reproduction globally

Nat. Rev. Urol. doi: /nrurol

Figure 2 Recruitment of experts to the Delphi study

Mapping of Pelvic Lymph Node Metastases in Prostate Cancer

Nat. Rev. Urol. doi: /nrurol

Volume 57, Issue 1, Pages (January 2010)

Figure 5 Types of urinary diversion

Figure 1 Cellular processes involved in cancer development

The Role of Lymphadenectomy in Radical Cystectomy

Nat. Rev. Urol. doi: /nrurol

Figure 3 Semantic model of the active surveillance (AS) timeline

Figure 4 BMI and mortality in patients with heart failure

Nat. Rev. Urol. doi: /nrurol

Volume 199, Issue 5, Pages (May 2018)

Figure 2 Representative images from a right radical

Figure 1 Anatomy of the femoral artery

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Figure 1 Key elements of the proposed modified Delphi study

Figure 2 Therapeutic targeting of the PI3K/AKT/mTOR pathway

Nat. Rev. Urol. doi: /nrurol

Figure 6 Common signalling mechanisms, pathways,

Volume 57, Issue 2, Pages (February 2010)

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Figure 1 The development process of the Asian

Figure 1 Differences in bladder cancer between genders

Figure 13 Proposed management of bladder cancer with variant histology

Nat. Rev. Urol. doi: /nrurol

Figure 1 Anatomy of the venous drainage from the testes

Figure 3 Treatment algorithm for adult infertile men with varicoceles

Figure 3 Algorithm for the determination of the clinical

Figure 1 Principles of therapeutic ultrasound

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Urol. doi: /nrurol

Figure 2 Temporal summation

Volume 53, Issue 1, Pages (January 2008)

Figure 6 Image sequence demonstrating coronal cuts on MRI

Figure 2 Global cost of HF per capita in 2012

Nat. Rev. Urol. doi: /nrurol

Video-Assisted Mediastinoscopic Lymphadenectomy (VAMLA)

Nat. Rev. Urol. doi: /nrurol

the SNP profile using 26 prostate cancer GWAS risk SNPs

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Figure 2 The evolution of brachytherapy for prostate cancer

Figure 5 Design of mushroom flap for glansplasty

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Figure 4 The grey zone between active

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Rashed Ghandour, Nirmish Singla, Yair Lotan Trends in Cancer

Presentation transcript:

Figure 3 Template for standard pelvic lymphadenectomy Figure 3 | Template for standard pelvic lymphadenectomy. Standard dissection includes the removal of the internal iliac, presacral, obturator fossa and external iliac nodes up to the bifurcation of the common iliac arteries, using the ureters as the medial border. Permission obtained from Elsevier © Zehnder, P. et al. J. Urol. 186, 1261–1268 (2011). Permission obtained from Elsevier © Zehnder, P. et al. J. Urol. 186, 1261–1268 (2011) Lobo, N. et al. (2017) Landmarks in the treatment of muscle-invasive bladder cancer Nat. Rev. Urol. doi:10.1038/nrurol.2017.82